延长俯卧位通气策略与插管COVID-19患者死亡率降低相关
本研究为多中心回顾性队列研究,纳入2020年3月11日至5月31日期间连续收治的接受俯卧位通气(PPV)的插管COVID-19患者,比较延长(≥24小时)与间歇(约16小时,每日仰卧位)PPV策略对死亡率的影响。结果显示,延长PPV组30天和90天全因死亡率均显著低于间歇PPV组,且俯仰位转换次数更少,总体PPV相关并发症无差异,但面部水肿发生率增加、俯卧位期间低血压发生率降低。
要点
- 延长PPV(≥24小时)较间歇PPV(约16小时)与插管COVID-19患者30天和90天死亡率降低相关。
- 在俯卧位时Pao2/Fio2≤150的患者中,延长PPV的生存获益更为明显。
- 延长PPV减少俯仰位转换次数,总体并发症无差异,但面部水肿增加、俯卧位期间低血压减少。
核心结论
- 在接受PPV的插管COVID-19患者中,延长PPV与30天和90天死亡率降低相关,且俯仰位转换次数更少、面部水肿轻度增加,提示延长PPV是安全有效的降低死亡率策略。
研究设计与样本
- 多中心回顾性队列研究,连续纳入2020年3月11日至5月31日期间接受PPV的插管COVID-19患者,延长PPV组157例,间歇PPV组110例,采用逆概率治疗加权(IPTW)控制治疗选择偏倚。
主要发现
- 延长PPV组较间歇PPV组30天死亡率降低(aHR 0.475;95%CI 0.336-0.670;P<.001),90天死亡率亦降低(aHR 0.638;95%CI 0.461-0.883;P=.006)。
- 在俯卧位时Pao2/Fio2≤150的患者中,延长PPV与30天死亡率降低相关(aHR 0.357;95%CI 0.213-0.597;P<.001),90天死亡率降低(aHR 0.562;95%CI 0.357-0.884;P=.008)。
- 延长PPV组俯仰位转换事件中位数为1次(95%CI 1-2),间歇PPV组为3次(95%CI 1-4),P<.001。
- PPV策略与总体PPV相关并发症无关联,但延长PPV组面部水肿发生率增加、俯卧位期间低血压发生率降低。
临床怎么用
- 对于接受俯卧位通气的插管COVID-19患者,可考虑采用延长(≥24小时)PPV策略以降低死亡率,尤其适用于俯卧位时Pao2/Fio2≤150的患者。
- 延长PPV可减少俯仰位转换次数,但需关注面部水肿的发生,同时俯卧位期间低血压发生率较低。
局限性
- 本研究为回顾性队列研究,尽管采用IPTW控制选择偏倚,仍可能存在未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prone position ventilation (PPV) is resource-intensive, yet the optimal strategy for PPV in intubated patients with COVID-19 is unclear. RESEARCH QUESTION: Does a prolonged (24 or more h) PPV strategy improve mortality in intubated COVID-19 patients compared with intermittent (∼16 h with daily supination) PPV? STUDY DESIGN AND METHODS: Multicenter, retrospective cohort study of consecutively admitted intubated COVID-19 patients treated with PPV between March 11 and May 31, 2020. The primary outcome was 30-day all-cause mortality. Secondary outcomes included 90-day all-cause mortality and prone-related complications. Inverse probability treatment weights (IPTW) were used to control for potential treatment selection bias. RESULTS: Of the COVID-19 patients who received PPV, 157 underwent prolonged and 110 underwent intermittent PPV. Patients undergoing prolonged PPV had reduced 30-day (adjusted hazard ratio [aHR], 0.475; 95% CI, 0.336-0.670; P < .001) and 90-day (aHR, 0.638; 95% CI, 0.461-0.883; P = .006) mortality compared with intermittent PPV. In patients with Pao2/Fio2 ≤ 150 at the time of pronation, prolonged PPV was associated with reduced 30-day (aHR, 0.357; 95% CI, 0.213-0.597; P < .001) and 90-day mortality (aHR, 0.562; 95% CI, 0.357-0.884; P = .008). Patients treated with prolonged PPV underwent fewer pronation and supination events (median, 1; 95% CI, 1-2 vs 3; 95% CI, 1-4; P < .001). PPV strategy was not associated with overall PPV-related complications, although patients receiving prolonged PPV had increased rates of facial edema and lower rates of peri-proning hypotension. INTERPRETATION: Among intubated COVID-19 patients who received PPV, prolonged PPV was associated with reduced mortality. Prolonged PPV was associated with fewer pronation and supination events and a small increase in rates of facial edema. These findings suggest that prolonged PPV is a safe, effective strategy for mortality reduction in intubated COVID-19 patients.
引用
- Okin D, Huang CY, Alba GA, et al. Prolonged Prone Position Ventilation Is Associated With Reduced Mortality in Intubated COVID-19 Patients. Chest. 2022. PMID: 36343687. doi:10.1016/j.chest.2022.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。